/

Investors / United States / Connecticut Innovations

Connecticut Innovations

Venture capital · New Haven, CT, United States · North America

ctinnovations.com

Connecticut Innovations is Connecticut's strategic venture capital arm, providing financing and ongoing support to innovative, growing companies. It also runs funding programs such as an angel investor tax credit program and SSBCI technical assistance.

Invests inHealthcare & Biotech

In its own wordsbiotechitartificial intelligencequantumclimatetechdeep tech

Your fit with Connecticut Innovations

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
180portfolio companies
19funding rounds on record3 led
17rounds, last 12 months
$5M to $20Mtypical round it comes in at
Seedmost frequent entry
$200Mlatest fund

Connecticut Innovations lists 180 checked portfolio companies on its own site and is named in 19 funding rounds, 3 of them as lead. Its most frequent entry is Seed, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (35%), AI & Machine Learning (11%) and Fintech (11%). 81% of its companies are based in United States. It invests most often alongside Creative Destruction Lab, Elm Street Ventures and LaunchCapital.

Counts come from funding rounds that name Connecticut Innovations, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.

Round figures show recent activity, not Connecticut Innovations' whole history. Rounds on record name 19 companies; its own site lists 180. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.

Entry stage

share of companies by the stage of its first round
Show as a table
Share of companies by the stage of the firm's first round
Value
Pre-seed6%
Seed50%
Series A22%
Series B17%
Growth6%

Activity by year

rounds it joined, last 10 years
Show as a table
Funding rounds per year
TotalRounds it led
'1700
'1800
'1900
'2000
'2100
'2200
'2300
'2400
'2531
'26162

Investor profile

percentile among all firms
Portfolio size: 180 companiesRecent activity: 17 rounds in 12 monthsEarly stage: 56% of entries at pre-seed or seedEvidence: 8% of companies confirmed by a roundSector focus: 35% in its largest sectorReach: 8 countriesPortfolio size98th pctRecent activity98th pctEarly stage74th pctEvidence72th pctSector focus63th pctReach91th pct
This firmMedian of all firms
Show as a table
Connecticut Innovations compared with all firms
MeasurePercentile of all firmsValue
Portfolio size98th180 companies
Recent activity98th17 rounds in 12 months
Early stage74th56% of entries at pre-seed or seed
Evidence72th8% of companies confirmed by a round
Sector focus63th35% in its largest sector
Reach91th8 countries

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech35%15%
AI & Machine Learning11%18%
Fintech11%12%
Industrial & Manufacturing9%7%
Education6%7%
Cybersecurity4%4%
Consumer4%3%
E-commerce & Marketplaces4%6%

Invests most often with

firms sharing its portfolio companies
Show as a table
Co-investors
Share
Creative Destruction Lab7
Elm Street Ventures7
LaunchCapital5
Amplifyher Ventures3
Foothill Ventures3
Outsiders Fund3
Thynk Ventures3
Y Combinator3

All co-investors

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers17798%
  • No longer answers00%
  • Points to another company32%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Compare Connecticut Innovations head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Funds

as stated on its site
Connecticut Bioscience Innovation Fund$200M"$200 million" on its site
ClimateTech Fund$100M"$100 million" on its site
AI/Q Fund$50.0M"$50 million" on its site
Future Fund$50.0M"$50 million" on its site

Recent portfolio activity

when companies last raised with Connecticut Innovations
DateCompanyStage
29 Oct 2026Urologic Designurologicdesign.comPre-Seed
22 Oct 2026XRHealthxr.healthSeries A
14 Oct 2026Uviuvi.ioSeed Led
12 Oct 2026Loops AIgetloops.aiSeed
22 Sept 2026UltraSightultrasight.comSeries C+
7 Jul 2026Adaptive Insuranceadaptiveinsurance.comSeed
8 Jun 2026rejuvenatebio.comrejuvenatebio.comSeed
27 May 2026Cypher AIcypherbio.aiSeed

Round details for Connecticut Innovations

Amounts, full round histories and every co-investor in Connecticut Innovations' rounds are on Fundup AI. VCinfo covers investors and their portfolios.

See rounds on Fundup AI →

Portfolio

180 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Nuka Enterprises Llc Dba 19061906newhighs.comThe company sells hemp-derived THC and CBD products online.
Healthcare & Biotech
Portfolio page
Abbratechabbratech.com · United StatesAbbraTech discovers and engineers antibodies against disease targets using its Epivolve platform technology
Healthcare & Biotech
Portfolio page
Aceissaceiss.comAceiss protects against cyber attacks by revealing unauthorized use of employee access to company systems.
Cybersecurity
Portfolio page
Adaptive Insuranceadaptiveinsurance.com · United StatesAdaptive Insurance provides specialty insurance for climate and weather risk
FintechClimate & Energy
Jul 2026SeedPage + round
Advanced Telepsych Incadvancedtelepsych.org · United StatesAdvanced Telepsych Inc provides virtual mental health services
Healthcare & Biotech
Portfolio page
Aeromicsaeromics.com · United StatesAeromics is a clinical-stage pharmaceutical company developing a therapy for severe, acute ischemic stroke
Healthcare & Biotech
Portfolio page
Allyx Therapeuticsallyxthera.com · United StatesAllyx Therapeutics is developing oral small molecule therapies to treat Alzheimer's disease and neurodegeneration
Healthcare & Biotech
Portfolio page
Ampupampup.io · United StatesAmpUp makes EV charging easy for fleets, workplaces, multifamily communities, and public sites.
E-commerce & MarketplacesIndustrial & Manufacturing
Portfolio page
Apriligenapriligen.com · United StatesApriligen develops therapies for pediatric monogenic illnesses that have no cure.
Healthcare & Biotech
Portfolio page
Arccosarccosgolf.com · United StatesArccos tracks every aspect of a golfer's game to help them improve
ConsumerGaming
Portfolio page
Arvinasarvinas.comArvinas develops targeted protein degradation therapeutics for serious diseases, particularly in neurology and oncology.
Healthcare & Biotech
Portfolio page
Asarasi Incasarasi.comAsarasi Inc harvests and sells water from the sap of maple trees as a sustainable and renewable resource.
Food & Agriculture
Portfolio page
Athletic Brewing Companyathleticbrewing.comThe company produces and sells non-alcoholic beer
Food & Agriculture
Portfolio page
AtlasXomicsatlasxomics.comAtlasXomics brings chromatin accessibility, histone modifications, and gene expression into spatial context for researchers
Healthcare & Biotech
Portfolio page
Better Rhodesbetterrhodes.com · United StatesBetter Rhodes sells non-alcoholic drinks and beverages, including wine, beer, and spirits.
Food & Agriculture
Portfolio page
Bexorgbexorg.comBexorg develops a platform for drug discovery using AI and whole-human brain technology
Healthcare & Biotech
Portfolio page
Biohaven Pharmaceuticalsbiohavenpharma.comBiohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas including immunology, obesity, neuroscience and oncology.
Healthcare & Biotech
Portfolio page
Biologicsmdbiologicsmd.com · United States
Healthcare & Biotech
Portfolio page
Biowave Corporationbiowave.com · United StatesBioWave develops and provides neuromodulation products for pain relief
Healthcare & Biotech
Portfolio page
Bloom Creditbloomcredit.ioBloom Credit provides technology and data to help financial institutions make lending decisions and manage credit
FintechLegal & Compliance
Portfolio page

About this data

site last read 11 Nov 2026
The homepage of Connecticut Innovations, as last read
ctinnovations.com as VCinfo last read it
Site
ctinnovations.com
Last read
11 Nov 2026
Watching since
5 Nov 2026
Rounds since
15 Sept 2025
Companies checked
180

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Connecticut Innovations' profile as data

Pull Connecticut Innovations' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/ctinnovations.com

# also
GET /v1/firms/ctinnovations.com/portfolio
GET /v1/firms/ctinnovations.com/coinvestors
GET /v1/firms/ctinnovations.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing